Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q4 FY20 results · Jan–Mar 2020
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹656.05 crore (down 6.2% from Q4 FY19) and net profit of ₹91.10 crore (up 1.1% from Q4 FY19) for Q4 FY20 (Jan–Mar 2020), on a standalone basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 656.05 | 699.34 | −6.2% | 859.27 | −23.7% |
| Other income | 14.52 | 8.43 | +72.2% | 9.02 | +61.0% |
| Total income | 670.57 | 707.77 | −5.3% | 868.29 | −22.8% |
| Profit before tax | 124.87 | 138.98 | −10.2% | 182.00 | −31.4% |
| Net profit for the period | 91.10 | 90.11 | +1.1% | 135.93 | −33.0% |
| EPS, basic (₹) | 28.07 | 27.76 | +1.1% | 41.88 | −33.0% |
| Net margin (%) | 13.9 | 12.9 | 15.8 |
Standalone
- Filed with BSE
- 09 May 2020, 09:54 IST
- Board meeting
- 08 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE